US FDA approves Neurocrine Biosciences’ Crenessity to treat children and adults with classic congenital adrenal hyperplasia: San Diego Monday, December 16, 2024, 16:00 Hrs [IST] ...

The FDA has approved Neurocrine Bioscience's Crenessity for classic congenital adrenal hyperplasia (CAH), the first drug for ...

Neurocrine Biosciences stock jumped Monday after the company won FDA approval for the first new treatment for an adrenal disease in decade ...

After seven decades with no advances in the treatment of the genetic disorder classic congenital adrenal hyperplasia (CAH), ...

Crinecerfont is the first new treatment in 70 years for classic CAH and the only one that directly reduces excess ...

Type 2 diabetes is a chronic condition where the body becomes resistant to insulin or doesn't produce enough of it, leading ...

Psychotherapists are often the first mental health professionals individuals encounter. Yet, many are underinformed on the ...

Gameto, a biotechnology company dedicated to advancing treatment option in women's health, announced today the world's first live human birth using Fertilo, an ovarian support cell (OSC) technology ...

Some things come with the privilege of getting older — more wisdom, more birthdays, more stories to tell. But with age comes ...

Adopting a balanced diet, moderate exercise, restorative sleep, and limiting alcohol and caffeine significantly enhances IVF ...

Chronic high blood sugar, also known as hyperglycemia ... These approaches can work alongside prescribed treatments to ...

Cushing disease treatment outcomes were improved among patients with normalized late-night salivary and mean urinary free cortisol levels.